Ariprex™

Aripiprazole
Antipsychotics (CNS Preparations)

Indication:

Ariprex^TM is indicated for schizophrenia, bipolar disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, agitation associated with schizophrenia or bipolar mania.

Dosage & Administration:

Indications	Initial Dose	Recommended Dose	Maximum Dose
Schizophrenia – adults	10-15 mg/day	10-15 mg/day	30 mg/day
Schizophrenia – adolescents (ages 13-17 years)	2 mg/day	10 mg/day	30 mg/day
Bipolar mania – adults: monotherapy	15 mg/day	15 mg/day	30 mg/day
Bipolar mania – adults: adjunct to lithium or valproate	10-15 mg/day	15 mg/day	30 mg/day
Bipolar mania – pediatric patients (ages 10-17 years): monotherapy or as an adjunct to lithium or valproate	2 mg/day	10 mg/day	30 mg/day
As an adjunct to antidepressants for the treatment of major depressive disorder– adults	2-5 mg/day	5-10 mg/day	15 mg/day
Irritability associated with autistic disorder-pediatric patients (ages 6-17 years)	2 mg/day	5-10 mg/day	15 mg/day

• Oral formulations: Administer once daily without regard to meals

Preparation:

Ariprex^TM 2 Tablet: Box containing 30 tablets in blister pack

Ariprex^TM 10 Tablet: Box containing 30 tablets in blister pack

Ariprex^TM 15 Tablet: Box containing 30 tablets in blister pack

Ariprex^TM Oral Solution: Eack PET bottle contains 50 ml oral solution with measuring cup & dropper.